Cargando…

HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity

Adoptive cell therapy (ACT) with tumor-specific memory T cells has shown increasing efficacy in regressing solid tumors. However, tumor antigen heterogeneity represents a longitudinal challenge for durable clinical responses due to the therapeutic selective pressure for immune escape variants. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Andrew, Ho, Louisa, Hogg, Richard, Chen, Lan, Walsh, Scott R., Wan, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525113/ https://www.ncbi.nlm.nih.gov/pubmed/35972798 http://dx.doi.org/10.1172/JCI159283

Ejemplares similares

Multivalent Carbohydrate Nanocomposites for Tumor Microenvironment Remodeling to Enhance Antitumor Immunity
por: Hyun, Gyu Hwan, et al.
Publicado: (2023)

HDACIs and the inhibition of invasive potential
por: Dent, Paul
Publicado: (2013)

Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells
por: Gnedina, Olga O., et al.
Publicado: (2023)

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
por: Suraweera, Amila, et al.
Publicado: (2018)

The Role of HDACs and HDACi in Cartilage and Osteoarthritis
por: Zhang, He, et al.
Publicado: (2020)

CLU blocks HDACI-mediated killing of neuroblastoma
por: Subramanian, Chitra, et al.
Publicado: (2010)

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
por: Ververis, Katherine, et al.
Publicado: (2013)

HDACiDB: a database for histone deacetylase inhibitors
por: Murugan, Kasi, et al.
Publicado: (2015)

Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling
por: Valiuliene, Giedre, et al.
Publicado: (2015)

Epitope spreading
por: Vanderlugt, Carol J, et al.
Publicado: (1996)

Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity
por: Chen, Hsuan-An, et al.
Publicado: (2023)

Chromatin remodeling induced by histone deacetylase inhibitors (HDACis) in HeLa, NIH 3T3 and HepG2 cells
por: Felisbino, Marina B, et al.
Publicado: (2013)

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
por: Chan, Daniel, et al.
Publicado: (2013)

Vimentin, colon cancer progression and resistance to butyrate and other HDACis
por: Lazarova, Darina L., et al.
Publicado: (2016)

The Promising Role of New Generation HDACis in Anti-Cancer Therapies
por: Hervouet, Eric
Publicado: (2018)

Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source
por: Krasic, Jure, et al.
Publicado: (2020)

HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
por: Squarzoni, Angelica, et al.
Publicado: (2022)

Epitope spreading induced by immunization with synthetic SSB peptides
por: DING, MIN, et al.
Publicado: (2016)

Epitope Spreading and the Efficacy of Immune Checkpoint Inhibition in Cancer
por: Liu, W. Robert, et al.
Publicado: (2021)

Tumor immune microenvironment (TIME) to enhance antitumor immunity
por: Rajbhandary, Sajin, et al.
Publicado: (2023)

Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer
por: Losson, Hélène, et al.
Publicado: (2016)

HDACi and Nrf2: not from alpha to omega but from acetylation to OA
por: Jahr, Holger
Publicado: (2015)

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
por: Bayat Mokhtari, Reza, et al.
Publicado: (2017)

Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2021)

Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models
por: Ito, Ken, et al.
Publicado: (2017)

Nicotinamide: a Class III HDACi Delays In Vitro Aging of Mouse Oocytes
por: LEE, Ah Reum, et al.
Publicado: (2013)

PB2396: HDACI COMBINED WITH LB100 PROMOTES THE OCCURRENCE OF FERROZOSIS IN CTCL
por: Shi, Wenyu
Publicado: (2023)

Targeting the tumor microenvironment to enhance antitumor immune responses
por: Van der Jeught, Kevin, et al.
Publicado: (2014)

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
por: Yan, Yuheng, et al.
Publicado: (2022)

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
por: Zhang, Bin, et al.
Publicado: (2021)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
por: Grassadonia, Antonino, et al.
Publicado: (2013)

Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs)
por: Mackmull, Marie-Therese, et al.
Publicado: (2015)

Protective effect of HDACIs in improves survival and organ injury after CLP-induced sepsis
por: Niu, Kunwei, et al.
Publicado: (2023)

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2022)

Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
por: Horn, Lucas A, et al.
Publicado: (2020)

Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy
por: Sui, Xueqing, et al.
Publicado: (2020)

Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
por: Xu, Qian, et al.
Publicado: (2023)

Pan HDACi Valproic Acid and Trichostatin A Show Apparently Contrasting Inflammatory Responses in Cultured J774A.1 Macrophages
por: Ubah, Ubah Dominic Babah, et al.
Publicado: (2022)

Simultaneous selection of nanobodies for accessible epitopes on immune cells in the tumor microenvironment
por: Sekar, Thillai V., et al.
Publicado: (2023)

The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment
por: Lian, Jiachun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gnlvlb0qiqhdnonq0eq8ei3ej7